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Abstract
Extraintestinal pathogenic and intestinal pathogenic (diarrheagen-
ic) Escherichia coli differ phylogenetically and by virulence profiles.
Classic theory teaches simple linear descent in this species, where
non-pathogens acquire virulence traits and emerge as pathogens.
However, diarrheagenic Shiga toxin-producing E. coli (STEC) O2:H6
not only possess and express virulence factors associated with di-
arrheagenic and uropathogenic E. coli but also cause diarrhea and
urinary tract infections. These organisms are phylogenetically
positioned between members of an intestinal pathogenic group
(STEC) and extraintestinal pathogenic E. coli. STEC O2:H6 is, there-
fore, a heteropathogen, and the first such hybrid virulent E. coli
identified. The phylogeny of these E. coli and the repertoire of vir-
ulence traits they possess compel consideration of an alternate
view of pathogen emergence, whereby one pathogroup of E. coli
undergoes phased metamorphosis into another. By understanding
the evolutionary mechanisms of bacterial pathogens, rational strate-
gies for counteracting their detrimental effects on humans can be
developed.
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Introduction
Escherichia coli are usually harmless inhabitants of the human
gut. However, some members of this species have acquired
specific virulence attributes that allow them to cause intestinal as
well as extraintestinal diseases in humans (Kaper et al, 2004).
One important and instructive group of intestinal pathogenic
E. coli is the set of Shiga toxin (Stx)-producing E. coli (STEC).
STEC cause diarrhea, bloody diarrhea, and, because of toxemia
and not dissemination, the hemolytic uremic syndrome (HUS)
(Kaper et al, 2004; Karch et al, 2005). E. coli O157:H7 is the most
common human pathogenic STEC (Karch et al, 2005), but a vari-
ety of non-O157:H7 STEC serotypes have also been isolated from
patients (Karch et al, 2005; Mellmann et al, 2008; Bielaszewska
et al, 2013). These pathogens have acquired a rather stereotyped
suite of virulence loci (‘parallel evolution’) (Reid et al, 2000; Ogura
et al, 2009). Other well-defined intestinal E. coli pathogroups include
enteropathogenic (EPEC), enterotoxigenic (ETEC), enteroinvasive
(EIEC), enteroaggregative (EAEC), and adherent-invasive (AIEC)
E. coli (Nataro & Kaper, 1998; Darfeuille-Michaud, 2002; Kaper et al,
2004). Extraintestinal pathogenic E. coli (ExPEC) are classified as uro-
pathogenic (UPEC), sepsis-
associated, and meningitis-associated (MNEC) (Kaper et al, 2004).
Escherichia coli virulence and phylogeny are intertwined. Each
pathogenic E. coli group possesses ‘signature’ repertoires of viru-
lence genes, which enable them to colonize and injure their host
(Kaper et al, 2004). While exceptions exist, particularly among
ETEC (Turner et al, 2006), strains within pathogroups are often phy-
logenetically closely related (Achtman et al, 1983; Wirth et al,
2006). Current concepts of pathogen emergence employ linear
descent scenarios, where horizontal acquisition of pathogenicity
islands, bacteriophages, and plasmids by non-pathogens results in
phylogenetically fixed pathogroups (Dozois & Curtiss, 1999). Here,
we determined the phylogenetic relationship of STEC O2:H6 isolated
from patients with diarrhea to other intestinal and extraintestinal
pathogenic E. coli and then characterized the O2:H6 virulence genes
as well as their UPEC virulence potential. To our surprise, these
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analyses did not portray the linear emergence of pathogenicity by
step-wise recombination events, but, instead, identified STEC O2:H6
as a ‘transitional’ pathogen in the process of morphing between
pathogroups.
Results
Phylogeny of STEC O2:H6
Multilocus sequence typing (MLST) (Wirth et al, 2006) demon-
strates that 13 STEC O2:H6 strains isolated between 2000 and 2009
from epidemiologically unrelated patients with non-bloody diar-
rhea, whose illnesses resolved without progression to HUS and
whose stools contained no other intestinal pathogens belong to
sequence type (ST) 141 (supplementary Table S1). This ST is only
distantly related to the STs of the non-H6 STEC O2, and is not
found among STEC causing HUS (‘the HUSEC collection’)
(Mellmann et al, 2008), intestinal pathogenic E. coli strains of other
pathogroups (EPEC, ETEC, EIEC, EAEC, AIEC), prototypic ExPEC
(UPEC and MNEC) strains, and in a non-pathogenic E. coli K-12
(supplementary Table S1). Intriguingly, in the minimum spanning
tree based on allelic profiles of the seven MLST housekeeping genes
in combination with 53 genes encoding the bacterial ribosome pro-
tein subunits (rMLST) (Jolley et al, 2012) (supplementary Table
S2), STEC O2:H6 is positioned between the HUSEC and ExPEC
(including UPEC and MNEC) strains, in the proximity of AIEC
(Fig 1). In further phylogrouping (Clermont et al, 2000), the STEC
O2:H6 isolates localize to E. coli Reference (ECOR) (Selander et al,
1987) phylogenetic group B2, as do UPEC, MNEC (Table 1) and
AIEC (Dreux et al, 2013). In contrast, non-H6 STEC O2 and STEC in
the HUSEC collection (http://www.ehec.org) belong to phylogroups
A, B1, and D (Table 1).
To more thoroughly analyze the phylogenetic relationships
between STEC O2:H6, most closely related STEC (serotype O91:H21;
ST442; Fig 1) and prototypic HUS-associated STEC, UPEC and AIEC,
we used whole genome sequencing and a gene-by-gene analysis of
in total 2827 open reading frames that were present in all 14 strains
investigated (see supplementary Table S1). This analysis confirmed
the intermediate positioning of STEC O2:H6 between the major
HUS-associated STEC serotypes and UPEC. Interestingly, AIEC were
grouped closely to UPEC (Fig 2).
Virulence gene census of STEC O2:H6
We next sought various virulence genes of STEC, other intestinal
pathogenic E. coli, and ExPEC in the STEC O2:H6 isolates using PCR
and sequencing. STEC loci, including a stx2 allele (GenBank accession
no. GU126552) that is subtyped as stx2b encoding Stx2b (Scheutz
et al, 2012), and saa (encoding STEC autoagglutinating adhesin;
Saa) (Paton et al, 2001) were present in all STEC O2:H6 (Table 1). In
contrast, we failed to find loci typical for EPEC, including genes of
the locus of enterocyte effacement (LEE) (supplementary Table S3),
which are in most, but not all, HUSEC (Mellmann et al, 2008). Also,
none of the STEC O2:H6 possessed virulence factors typically found
in ETEC (heat-labile and heat-stable enterotoxins), EIEC (the inva-
sive plasmid pInv and Shigella enterotoxin 2), and EAEC (the EAEC
heat-stable enterotoxin 1, Shigella enterotoxin 1, the autotransporters
Pet and Pic, and the EAEC virulence plasmid) (Nataro & Kaper, 1998;
Vila et al, 2000; Kaper et al, 2004) (supplementary Table S3).
Because of their phylogenetic positioning between HUSEC and
ExPEC (Fig 1), and because E. coli O2:H6 have been isolated from
patients with urinary tract infections (Johnson et al, 2005), we
tested the STEC O2:H6 isolates for virulence factors of ExPEC.
Indeed, all STEC O2:H6 contain virulence genes typical of UPEC
(Table 1). These include putative or demonstrated urovirulence loci
encoding toxins (a-hlyA, cnf1, vat, clb island) (Johnson, 1991; John-
son & Stell, 2000; Parreira & Gyles, 2003; Johnson et al, 2005;
Nougayrede et al, 2006), adhesins (pap cluster, sfaII cluster, hek)
(Korhonen et al, 1982; Johnson, 1991; Hacker et al, 1993; Dobrindt
et al, 2002; Johnson et al, 2005), the contact-dependent inhibition
phenotype (cdiAB cluster) (Aoki et al, 2005), and iron acquisition
systems (iro cluster, yersiniabactin cluster) (Johnson & Stell, 2000;
Figure 1. Phylogenetic relationships of STEC O2:H6 to intestinal and
extraintestinal pathogenic Escherichia coli and to E. coli. K-12. Minimum
spanning tree based on MLST and rMLST allelic profiles portraying the clonal
relationships of STEC O2:H6 to HUS-associated STEC (HUSEC collection)
(Mellmann et al, 2008), other intestinal pathogenic E. coli (EPEC, ETEC, EIEC,
EAEC, AIEC), prototypic ExPEC including UPEC and MNEC isolates, and a non-
pathogenic E. coli strain K-12 (MG1655). Isolates are described in supplementary
Table S1. Each circle represents a given allelic profile (combination of MLST and
rMLST loci) and is named with the MLST sequence type. The different groups of
strains are distinguished by colors of the circles. The numbers on the connecting
lines illustrate the number of differing alleles.
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Dobrindt et al, 2002). Notably, these ExPEC virulence genes were
rare in non-H6 STEC O2 and in strains of the HUSEC collection
(Table 1).
As AIEC were also phylogenetically closely related to UPEC and
to STEC O2:H6 (Figs 1 and 2), we further investigated whether
STEC O2:H6 strains contain FimH belonging to the same clade as
that possessed by UPEC and AIEC strains (Sepehri et al, 2009).
FimH is the adhesin subunit of the type 1 pili that mediate adher-
ence and play an essential role in the invasive ability of AIEC
(Boudeau et al, 2001). Comparative sequence analysis of FimH from
the sequenced STEC O2:H6 strains (supplementary Table S1) and
from the UPEC (strains 536, UTI89, CFT073) and AIEC (strains
LF82, LF73) reference strains showed the phylogenetic positioning
of all FimH proteins of STEC O2:H6 in the S70/N78 FimH clade
(supplementary Fig S1), which is typical for UPEC and AIEC (Dreux
et al, 2013).
Expression of STEC and UPEC virulence genes in STEC O2:H6
All STEC O2:H6 expressed Stx, as evidenced by the cytotoxicity of
their supernatants to Vero cells (reciprocal titer range, 8–256;
median, 32), and Saa (supplementary Fig S2).
Nearly all of the identified UPEC virulence loci were also
expressed by the cognate STEC O2:H6 isolates. Each of the ten
STEC O2:H6 that harbored a-hlyA and cnf1 (Table 1) produced
a-hemolysin on blood agar and cytotoxic necrotizing factor (CNF)
1, detectable as an ~115-kDa band in an immunoblot (supplemen-
tary Fig S3). Each of the three a-hlyA-negative, cnf1-negative and
clb-positive STEC O2:H6 (Table 1) produced colibactin, a hybrid
polyketide-peptide cyclomodulin encoded by the clb island
(Nougayrede et al, 2006). Similar to prototypic colibactin-produc-
ing MNEC strain IHE3034 (Nougayrede et al, 2006), each STEC
O2:H6 strain arrested HeLa cells in the G2 phase of the cell cycle
after 48 h and distended these epithelial cells and their nuclei,
converting them into megalocytes (Fig 3). In the ten remaining
clb-positive isolates, HeLa cell lysis caused by a-hemolysin con-
founded our attempts to study colibactin expression. Neither G2
arrest nor cell distension were elicited by a clb-negative, Stx2-
producing STEC O2:H27 (Fig 3), excluding a contribution of Stx
to these effects.
The contact-dependent growth inhibition phenotype (Aoki et al,
2005), encoded by the cdiAB cluster, was sought in three randomly
selected STEC O2:H6 (Fig 4). Each of these strains inhibited growth
of the target E. coli MG1655/pBluescript KS II(+) strain during the
Table 1. Virulence loci and phylogeny of STEC O2:H6 as compared to non-H6 STEC O2, HUSEC and prototypic UPEC and MNEC strains
Gene or gene
clustera of
Presence of the locus in strain(s) (% no. of strains)b
O2:H6
STEC
O2:H4
STEC
O2:H27
STEC
O2:H29
STEC
HUSEC
STEC
536
UPEC
CFT073
UPEC
J96
UPEC
UTI89
UPEC
S88
MNEC
IHE3034
MNEC
STEC
stxc 13 (100)
(stx2b)
+
(n.k.)
+
(stx2a)
+
(stx2c)
42 (100)
(stx1a, stx1c,
stx2a, stx2b,
stx2c, stx2d)
     
saa 13 (100)    6 (14.3)      
ExPEC
a-hlyA 10 (76.9)d    1 (2.4) + + + +  
cnf1 10 (76.9)d    0   + +  
vat 13 (100)    0 + + + + + +
clb island 13 (100)    0 + + + +  +
pap cluster 10 (76.9)d    0 + + + + + 
sfaII cluster 9 (69.2)    0    +  +
hek 10 (76.9)d    1 (2.4) +  + +  +
cdiAB cluster 13 (100)   + 6 (14.3) + + + +  
iro cluster 12 (92.3)    0 + + + + + +
ybt cluster 13 (100) +   13 (31.0) + + + + + +
Phylogroup B2 D A B1 A, B1, D B2 B2 B2 B2 B2 B2
ST (MLST)e 141 405 10 515 See Fig 1 127 73 12 95 95 95
aThe genes encode following proteins: stx, Shiga toxin; saa, STEC autoagglutinating adhesin; a-hlyA, a-hemolysin; cnf1, cytotoxic necrotizing factor 1; vat,
vacuolating autotransporter toxin; clb island, colibactin; pap cluster, P fimbriae; sfaII cluster, S fimbriae, subtype SfaII; hek, Hek adhesin; cdiAB, contact-
dependent inhibition phenotype; iro cluster and ybt cluster, yersiniabactin siderophore systems.
bIn STEC O2:H6 (n = 13) and HUSEC strains (n = 42), the number (%) of strains positive for the locus is shown; for non-H6 O2 STEC and UPEC and MNEC strains
(each n = 1), the presence (+) or absence () of the gene is indicated.
cstx subtypes are shown. stx2 (GenBank accession no. GU126552) subtyped as stx2b is present in all sequenced STEC O2:H6 (supplementary Table S1). For stx
genes in HUSEC strains see http://www.ehec.org and (Mellmann et al, 2008). STEC O2:H4 lost stx before subtyping (stx subtype is not known (n.k.)).
dThe genes are present in the same strains.
eST, sequence type; MLST, multilocus sequence typing.
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6 h observation period, as did the prototypic cdiAB-harboring strain
EC93 (Aoki et al, 2005). In contrast, cdiAB-negative STEC O2:H27
had no inhibitory effect (Fig 4).
vat, encoding vacuolating autotransporter toxin (Vat) (Parreira &
Gyles, 2003), was expressed in all 13 vat-positive STEC O2:H6 as
demonstrated by the ability of culture supernatants to produce vacu-
oles in Chinese hamster ovary (CHO) cells (Fig 5).
P and S fimbriae were expressed in eight of ten and six of nine
strains, harboring these respective loci (Table 1), as demonstrated
by the ability of the bacteria to agglutinate human and bovine ery-
throcytes, respectively, in the presence of mannose (Blumer et al,
2005). Thus, the UPEC virulence loci found in STEC O2:H6 are
largely functional across the collection of strains that we studied.
Analysis of urovirulence of STEC O2:H6
The ability of randomly selected STEC O2:H6 isolates to cause uri-
nary tract infection (UTI) was tested in an experimental murine
model of ascending UTI. The bacterial numbers in the bladder and
the kidneys were determined 72 h after infection (Fig 6). The proto-
typic UPEC strain 536 and STEC O2:H6 strain 05-00787 were recov-
ered in nearly equal numbers from the bladder tissue (1 × 105–
1 × 106 colony-forming units (CFU)/g bladder) (Fig 6A). Bladder
colonization by STEC O2:H6 strains 04-00955 and 03-08304 resulted
in 10-fold higher organ loads relative to UPEC 536. In all four cases,
bacterial concentrations in the bladder tissue were significantly
higher than after infection with non-pathogenic E. coli K-12 strain
MG1655 (Fig 6A). All three STEC O2:H6 strains also colonized the
kidneys as efficiently as UPEC strain 536 (Fig 6B). In contrast, strain
MG1655 was unable to ascend to the kidneys (Fig 6B). Conse-
quently, the potential of STEC O2:H6 strains to cause UTI in this
model is comparable to that of classic UPEC strain 536.
Figure 2. Phylogenetic relationships of STEC O2:H6 to prototypic UPEC,
AIEC and most closely related and prototypic HUS-associated STEC based
on whole genome sequencing. Minimum spanning tree is based on allelic
profiles of 2827 genes present in all strains investigated (see supplementary Table
S1). The different pathotypes are distinguished by colors of the circles and the
serotypes and strain numbers (in parentheses) are given.
A B
C D
Figure 3. Production of colibactin by STEC O2:H6. HeLa cells were cocultured with bacteria (4 h), washed and incubated in gentamicin-supplemented medium (48 h).
The DNA content was determined by flow cytometry and morphological changes were assessed microscopically. Bar = 100 lm.
A Uninfected (control) cells were mostly in the G1 phase of the cell cycle (2n DNA) and retained normal morphology.
B–C Cells infected with clb-positive STEC O2:H6 strain 05-00787 (B) or the prototypic clb-harboring strain IHE3034 (C) were arrested in the G2 phase (4n DNA) and
converted into megalocytes. (The phenotype shown in (B) was produced by each of three clb-positive, a-hlyA-negative and cnf1-negative STEC O2:H6).
D Cells infected with clb-negative Stx2-producing O2:H27 isolate displayed neither G2 arrest nor distension.
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Discussion
The clinical significance of hybrid pathogens was clearly demon-
strated by the deadly 2011 outbreak caused by E. coli O104:H4
(Bielaszewska et al, 2011; Frank et al, 2011; Karch et al, 2012). The
outbreak started in Germany in May 2011 and subsequently spread
to other European countries and North America, affecting in total
nearly 4000 persons of which more than 900 developed HUS and 54
died (Karch et al, 2012). The outbreak strain uniquely combined vir-
ulence genes typical for STEC and EAEC and expressed the pheno-
types that define these pathogroups including Stx2 production and
aggregative adherence to intestinal epithelial cells (Bielaszewska
et al, 2011; Brzuszkiewicz et al, 2011; Mellmann et al, 2011; Rasko
et al, 2011), the features that likely increased its virulence. This out-
break, therefore, tragically illustrated that blended virulence profiles
in enteric pathogens introduced into susceptible populations can
have serious public health consequences (Karch et al, 2012). More-
over, this outbreak highlighted the lack of our knowledge of the
basic principles of evolutionary trends of new pathogens as demon-
strated by the fact that the origin of the E. coli O104:H4 hybrid and
its evolutionary history remain obscure.
In this context, our identification of another hybrid pathogen,
STEC O2:H6 in this study, and gaining insight into its evolutionary
role is of particular importance, because we can determine the phy-
logenetic coordinates of its evolution. Also, STEC O2:H6 is the first
hybrid pathogen to demonstrate pluripotential pathogenicity in
intestinal and extraintestinal milieus, as predicted by its virulence
repertoire. Specifically, STEC O2:H6 occupies an evolutionary and
pathogenic interface between intestinal and extraintestinal patho-
genic E. coli, and several lines of evidence corroborate this assign-
ment: sequence typing, virulence genotyping and phenotyping, and
the clinical potential. First, MLST/rMLST, employing sequences of a
sample of housekeeping and ribomosal genes scattered around a
chromosomal backbone, agnostically placed these isolates between
HUSEC and ExPEC (Fig 1). Also whole genome sequencing of STEC
O2:H6, closely related HUS-associated STEC, and prototypic HUSEC,
AIEC and UPEC strains positioned STEC O2:H6 separately from the
other pathotypes in an intermediate position (Fig 2). Next, STEC
O2:H6 contain UPEC and HUSEC virulence genotypes and pheno-
types, using ascertainments independent of sequence typing, a find-
ing that appears highly non-random. While it is possible that chance
acquisition of a gene encoding Stx via phage transduction into either
a commensal E. coli or an ExPEC could have resulted in STEC O2:
H6, our data argue in favor of true UPEC/HUSEC heteropathogeni-
city. Specifically, the phylogeny places STEC O2:H6 at quite a
distance from commensal E. coli, and at moderate distances from
ExPEC (including UPEC) and from HUSEC (Fig 1). Hence, the STEC
O2:H6 are incarnated as a phylogenetically recognizable group, and
one that differs from UPEC (Figs 1 and 2). Also, an additional viru-
lence gene found in a subset of HUSEC, saa, encoded independently
on a plasmid (Paton et al, 2001) (unlike stx which is encoded on a
bacteriophage that integrates into the chromosome) was present in
all STEC O2:H6, in addition to the many UPEC virulence loci. This
simultaneous convergence on UPEC and STEC phylogeny and viru-
lence profiles is most simply explained by a phased transition from
one group of pathogens to the other. This is also corroborated by
the whole genome sequence data, where STEC O2:H6 strains repre-
sent a separate lineage (Fig 2) indicating that the core genome has
Figure 4. Contact-dependent growth inhibition mediated by STEC O2:
H6. Ampicillin-resistant target strain MG1655/pBlueskript KS II(+) was cultured
alone or in mixture with log-phase culture of each inhibitor (inhibitor-to-target
ratio 50:1) including cdiAB-positive STEC O2:H6 strains 03-08304, 05-06793, 04-
03909, prototypic cdiAB-harboring strain EC93, or cdiAB-negative STEC O2:H27. At
each indicated time point, the growth of the target strain (CFU/ml) was
determined by plating 10-fold culture dilutions on LB agar with ampicillin. Data
represent means  standard deviations of three independent experiments.
*P < 0.01 (unpaired Student′s t-test), differences between growth of the target
strain alone and in coculture with each respective inhibitor.
A B
C D
Figure 5. Vacuolization induced by STEC O2:H6. CHO cells were exposed to
sterile culture supernatants of tested strains and presence of vacuoles was
sought microscopically after 24 h. Bar = 20 lm.
A–B vat-positive STEC O2:H6 strains 05-00787 (A) and 05-06739 (B).
(Vacuolization similar to that displayed by these two strains was elicited
by all STEC O2:H6 isolates).
C vat-containing UPEC strain J96 (positive control).
D Uninfected cells (negative control).
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co-evolved with the virulence attributes. Finally, the heteropatho-
genic clinical potential of STEC O2:H6 is demonstrated by their abil-
ity to cause diarrhea in the human host and experimental UTI in
mice. The evolution of STEC O2:H6 via a phased pathotype transi-
tion is overall different from that of the E. coli O104:H4 hybrid,
which combines an EAEC genomic background with the presence of
stx characteristic of STEC. However, both evolutionary models of
this pathogen (Brzuszkiewicz et al, 2011; Mellmann et al, 2011;
Rasko et al, 2011) suggest a classic linear evolution from a progeni-
tor with reduced intestinal virulence via loss and/or acquisition of
various mobile elements such as bacteriophages, genomic islands or
plasmids (Brzuszkiewicz et al, 2011; Mellmann et al, 2011; Rasko
et al, 2011). AIEC are, similar to STEC O2:H6, phylogenetically
located between ExPEC (including UPEC) and intestinal pathogenic
E. coli (Fig 1). Our in-depth analysis based on the whole genome
sequencing and core genome analysis corroborated this fact and
positioned AIEC even closer to UPEC (Fig 2). These data, together
with the recently published genome sequence of the prototypic AIEC
isolate LF82 (Miquel et al, 2010), demonstrate the genetic hybrid
character of AIEC. However, as AIEC strains have only been associ-
ated with Crohn’s disease (Darfeuille-Michaud et al, 1998; Darfeu-
ille-Michaud, 2002) and not detected in human extraintestinal
diseases, they cannot be considered, in contrast to STEC O2:H6, as
heteropathogens from the clinical standpoint.
The heteropathogenicity of E. coli O2:H6 has multiple implica-
tions for our conceptualization of bacterial evolution and pathogen
emergence. First, and most significantly, the ‘missing link’ phylog-
eny and virulence traits of STEC O2:H6 suggest that pathogenic
E. coli emerge not only by the simple linear acquisition of virulence
loci by non-pathogenic E. coli strains. We speculate, based on our
data, that one pathogroup gradually exchanges one suite of viru-
lence loci for those of another pathogroup, as its core genome tran-
sitions simultaneously and in the same direction in a process of
‘phased metamorphosis’. This emergence model differs considerably
from a linear ‘pathogenic stem cell’ descent scenario because meta-
morphosis implies that a pathogenic E. coli in a given venue and
phylogeny retains alternative virulence options. Certainly, the step-
wise scenario whereby non-virulent (or less virulent) progenitors of
pathogens acquire virulence genes resulting in pathogen emergence
(Dozois & Curtiss, 1999) is appropriate for tightly circumscribed
groups of pathogens, such as the enterohemorrhagic E. coli (EHEC)
1 clade (Leopold et al, 2009) or the recent E. coli O104:H4 outbreak
strain, where, most plausibly, an EAEC acquired a Stx2-encoding
bacteriophage (Bielaszewska et al, 2011; Brzuszkiewicz et al, 2011;
Mellmann et al, 2011; Rasko et al, 2011). We wish to note that the
latter pathogen, while possessing blended genotypes and pheno-
types of EAEC and STEC, has a largely linear descent method of evo-
lution, because it is phylogenetically closely related to an EAEC
prototype strain 55989 (Brzuszkiewicz et al, 2011; Mellmann et al,
2011; Rasko et al, 2011). However, linear models might not apply
across the broader E. coli genospecies, where evolution and patho-
gen emergence might be more trabeculated. Our data are compatible
with a recent description of the complex and highly interwoven evo-
lutionary history of E. coli (Touchon et al, 2009), including the flow
of specific ‘highways’ of gene exchange (Leopold et al, 2011).
Our data actually validate the concept that virulence is ordained
by phylogeny as well as by genes encoding specific effector mole-
cules (Whittam et al, 1993). Specifically, the phylogenetic position-
ing of the STEC O2:H6 isolates between STEC and ExPEC (including
UPEC) (Figs 1 and 2) and their possession of virulence loci from
both STEC and UPEC (Table 1), reflect the co-evolution of the core
chromosome with the accrual of virulence traits of the two closest
pathogroups. Notably, loci specific for other pathogroups, such as
those common to EPEC, ETEC, EIEC, or EAEC, are not present.
Shiga toxin-producing Escherichia coli are rare among urinary
strain set collections. Johnson et al (Johnson et al, 2002) screened
597 UPEC isolates, and found no STEC, even though presumably
non-toxigenic E. coli O2:H6 might have been in this collection.
Indeed, E. coli O2:H6 accounted for 2.9% of UPEC isolated by these
investigators in another study (Johnson et al, 2005). STEC O2:H6 is
also rare in fecal samples from patients with diarrhea (Pierard et al,
1990) and absent from the HUSEC collection (Mellmann et al,
2008). The paucity of these organisms in large strain collections
prompts us to speculate that possession of traits of intestinal and
urinary pathogroups might reduce the ability of an organism to
cause disease in either venue. Nevertheless, the heteropathogenic
potential of these strains is substantiated by their isolation as the
only pathogens from stools of epidemiologically unrelated patients
A B
Figure 6. Urovirulence of STEC O2:H6 strains. Bladder (A) and kidney (B) colonization levels were determined 72 h after transurethral inoculation of mice with UPEC
strain 536 (positive control), the STEC O2:H6 strains 05-00787, 04-00955, and 03-08304, or non-pathogenic Escherichia coli K-12 strain MG1655 (negative control). Horizontal
bars represent the mean CFU number of each strain per gram of tissue; the whiskers display the respective standard error of the mean. Significant differences in the bacterial
organ load compared to the negative control are indicated by asterisks.
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with diarrhea in this study, and their identification as diarrheagenic
in other studies (Pierard et al, 1990), and their ability to cause UTI
in an animal model.
The heteropathogenic nature of STEC O2:H6 warrants additional
comments. The transitional nature of phased metamorphosis differs
from parallel and convergent evolution. Specifically, this model
portrays pathogens evolving along a continuum, with the backbone
changing in synchrony with virulence loci. Our data clearly recom-
mend combining backbone phylogeny assignment by MLST/rMLST
and whole genome sequencing with a broad spectrum virulence
profiling to discern metamorphosis between E. coli pathogroups.
While backbone analysis (i.e. the combination of MLST, rMLST and
whole genome sequencing in this case) accomplishes phylogenetic
positioning, its combination with virulence profiles provides a more
textured picture of evolution, and enabled us to propose this
alternate mechanism of pathogen emergence. Application of such
orthogonal assessments to additional isolates in other serotypes
should determine the extent to which other heteropathogenic E. coli
are found among the E. coli species, an association that might be
obscured by microbiologists′ focusing only on diagnostically and
pathogenetically relevant virulence factors.
In summary, STEC O2:H6 is an extant ‘way station’ between
major groups of pathogenic E. coli. It affords a unique opportunity
to study pathogen emergence via pathogroup conversion, and intro-
duces phased metamorphosis as a new evolutionary concept.
Broader surveys combining backbone phylogeny and systematic vir-
ulence gene enumeration will be needed to determine if this form of
pathogen emergence via transition is a generalized process.
Materials and Methods
Bacterial strains
The STEC O2, other intestinal pathogenic E. coli, and ExPEC strains
used in this study are listed in supplementary Table S1. Except for
an STEC O2:H29 (Tasara et al, 2008) (gift of R. Stephan, University
of Z€urich, Z€urich, Switzerland), all the other STEC O2 strains origi-
nated in Germany and represent all STEC of this serogroup recov-
ered in the European authors′ laboratories. HUSEC strains
(Mellmann et al, 2008) and their characteristics are available at
http://www.ehec.org. The MLST data and the phylogenetic groups
of the EPEC, ETEC, EIEC, EAEC, AIEC, UPEC and MNEC strains,
and E. coli K-12 strain MG1655 were derived from the published
genome sequences at http://www.ncbi.nlm.nih.gov. E. coli strain
EC93 used as a control in growth inhibition experiments has been
previously described (Aoki et al, 2005) and was a gift of D. A. Low
(University of California-Santa Barbara, Santa Barbara, CA, USA).
MLST, rMLST, PCR phylogrouping and whole genome sequencing
Internal fragments of seven housekeeping genes were sequenced
(Wirth et al, 2006) and STs were assigned according to the E. coli
MLST website (http://mlst.ucc.ie/mlst/dbs/Ecoli). Similarly,
sequences of the 53 rMLST loci were determined, alleles were
assigned in accordance to the rMLST database (Jolley et al, 2012)
and listed in supplementary Table S2. The minimum spanning tree
based on the MLST and rMLST allelic profiles (in total 60 loci, ca.
24.6 kb) was generated using the SeqSphere software version 0.9
beta (Ridom GmbH, M€unster, Germany). Classification into ECOR
phylogenetic groups A, B1, B2, and D was performed as described
(Clermont et al, 2000). For whole genome shotgun sequencing of
selected O2:H6 strains (see supplementary Table S1), sequencing
libraries were prepared using the Nextera XT chemistry (Illumina
Inc., San Diego, CA, USA) for either a 100 bp or a 250 bp paired-
end sequencing run on an Illumina HiScanSQ or MiSeq sequencer in
accordance to the manufacturer′s recommendations (Illumina).
After quality trimming using the default parameters of the CLC
Genomic Workbench software (CLC bio, Arhus, Denmark) the
sequencing reads were assembled using the CLC Genomic Work-
bench de novo assembler (CLC bio). Gene sequences for subsequent
analyses were extracted from contigs using the Ridom Seqsphere
software version 0.9 beta (Ridom GmbH). For the gene-by-gene core
genome analysis as described (Mellmann et al, 2011), we included
all genes present in all strains analyzed (see supplementary Table
S1). The whole genome sequence reads have been deposited at ENA
SRA (study accession no. PRJEB4756).
FimH sequencing
FimH protein sequences were derived from the whole genome
sequences and translated using the Ridom Seqsphere software ver-
sion 0.9 beta (Ridom GmbH). The Neighbor-joining tree of the FimH
sequences was created using the MEGA software (Tamura et al,
2011). For comparison, the published sequences of AIEC/UPEC typi-
cal FimH alleles (Dreux et al, 2013) were included.
Genotypic characterization
We used published PCR methodologies to find evidence of putative
virulence genes associated with STEC, such as those encoding toxins
(stx, EHEC-hlyA, cdt-III, cdt-V and subAB operons), serine proteases
(espP, espI), adhesins (eae, saa, lpfAO26, lpfAO113, lpfAO157-OI141,
lpfAO157-OI154, efa1, sfpA), LEE-encoded type III secretion system
(escV) and secreted proteins (espF, map, espG) (Friedrich et al,
2003; Gauthier et al, 2003; Bielaszewska et al, 2004, 2005b; Dahan
et al, 2004; Mairena et al, 2004; Paton et al, 2004; Toma et al, 2004;
Brockmeyer et al, 2007), and with UPEC including a-hlyA, cnf1,
cdt-I and cdt-IV operons, vat, sat, pap cluster (papACEFGH), sfaAI,
sfaII cluster (sfaAGSHII), focA, focG, sfrA, and hek (Blum et al,
1995; Johnson & Stell, 2000; Dobrindt et al, 2001, 2002; Bie-
laszewska et al, 2004; Ewers et al, 2005), as well as genes encoding
iron acquisition systems such as iro cluster (iroNEDCB), and the yer-
siniabactin cluster (ybtS, ybtQ, ybtA, irp2, irp1, ybtU, ybtT, ybtE,
fyuA) (Karch et al, 1999; Sorsa et al, 2003). The yersiniabactin clus-
ter is characteristic of UPEC and MNEC (Johnson & Stell, 2000; Dob-
rindt et al, 2002; Sorsa et al, 2003) but has also been found in a
subset of STEC (Karch et al, 1999). Moreover, the presence of the
cdiAB cluster and the clb island was sought using PCRs listed in sup-
plementary Table S4; the specificity of amplicons from these PCRs
introduced in this study was confirmed by sequence analysis using
Sanger sequencing. In addition, STEC O2:H6 were PCR-tested for
virulence loci typical for other intestinal pathogenic E. coli including
ETEC (elt and estI encoding heat-labile and heat-stable enterotoxin,
respectively), EIEC (ial, a marker for the virulence plasmid pInv,
and sen encoding a homologue of Shigella enterotoxin 2), and EAEC
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(set1, astA, pic and pet encoding Shigella enterotoxin 1, EAEC heat-
stable enterotoxin 1, autotransporters Pic and Pet, respectively, and
aatA, a marker for the EAEC virulence plasmid) (Nataro & Kaper,
1998; Vila et al, 2000).
Sequence analysis of stx genes
stx genes of six randomly selected STEC O2:H6 strains (supplemen-
tary Table S1) were amplified and Sanger sequenced; resulting
sequences were analyzed using the SeqSphere software version 0.9
beta (Ridom GmbH) and homologies were sought in GenBank
(http://www.ncbi.nlm.nih.gov/BLAST). The stx2 sequence from
strain 03-08304 (representative of those present in all six sequenced
strains) (stx2b subtype) was deposited in GenBank (accession no.
GU126552).
Phenotype determinations
Stx titers were determined by Vero cell cytotoxicity (Bielaszewska
et al, 2006), and production of a-hemolysin was determined on
Columbia blood agar (Heipha, Heidelberg, Germany) after overnight
incubation. Production of Saa and CNF1 was assayed by immuno-
blot (Paton et al, 2001). Briefly, lysates of overnight Luria-Bertani
(LB) broth cultures were subjected to sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE), separated proteins were
transferred to a membrane (Immobilon P, Roth, Karlsruhe, Ger-
many) and probed with polyclonal mouse anti-Saa antibody (Paton
et al, 2001) (a gift from J. C. Paton, Adelaide University, Adelaide,
Australia) or monoclonal mouse antibody against CNF1 + CNF2
(clone JC4) (Abcam, Cambridge, UK). Bound antibodies were
detected using alkaline phosphatase-conjugated goat anti-mouse IgG
(Dianova, Hamburg, Germany).
Colibactin expression was tested (Nougayrede et al, 2006) using
HeLa cells (ATCC CCL-2) maintained in Eagle minimum essential
medium supplemented with 10% fetal calf serum (FCS), 2 mM L-
glutamine, and 1% non-essential amino acids (Cambrex Bioscience,
Verviers, Belgium). For cell cycle analysis, the cells were cultured in
12-well plates seeded with 7.5 × 104 cells per well. Semiconfluent
monolayers were infected with overnight LB broth cultures of tested
isolates diluted in interaction medium (culture medium with 5%
FCS) to a multiplicity of infection (number of bacteria per cell)
~100:1, and cocultured for 4 h (37°C, 5% CO2). Cells were then
extensively washed and incubated in full fresh medium supple-
mented with gentamicin (200 lg/ml) for 48 h. After harvesting, the
cells were stained with propidium iodide-containing Nicoletti buffer
(Bielaszewska et al, 2005a) and the DNA content of the nuclei was
analyzed by flow cytometry on FACScalibur (Becton Dickinson, Hei-
delberg, Germany) as described previously (Bielaszewska et al,
2005a). For the cell distension assay, HeLa cells (3 × 104 per well)
were seeded into 24-well microtiter plates. Semiconfluent monolay-
ers were exposed for 4 h to overnight bacterial cultures as described
above, the cells were then washed, and incubated in full medium
with gentamicin for 48 h; morphology of native cells was examined
using a light microscope (Axiovert 40; Zeiss, Jena, Germany).
Contact-dependent growth inhibition was determined (Aoki et al,
2005) using three randomly selected cdiAB-positive STEC O2:H6
strains and an cdiAB-negative STEC O2:H27 strain as inhibitors and
E. coli K-12 strain MG1655 transformed with pBluescript KS II(+)
(Stratagene, La Jolla, CA, USA) encoding ampicillin resistance as a
target strain. Briefly, a log-phase LB broth culture of each inhibitor
strain was mixed (ratio 50:1) with a stationary culture of E. coli
MG1655/pBluescript KS II(+) and cocultured (37°C, 225 rpm) for
1.5, 3, 4.5, and 6 h. At each time point, growth of the target strain
incubated with each inhibitor and alone (growth control) was deter-
mined (CFU/ml) by plating 10-fold dilutions of the cultures on LB
agar with ampicillin (100 lg/ml) (to which all inhibiting bacteria
were susceptible).
To determine if the isolates expressed Vat, CHO-K1 cells (ACC
110; German collection of microorganisms and cell cultures, Braun-
schweig, Germany) were seeded in 24-well plates (4 × 103 cells per
well) in Ham′s F12 medium with 10% of FCS (Cambrex). The cells
were incubated with sterile overnight culture supernatants of the
strains for 24 h (37°C, 5% CO2) and vacuoles were sought by
microscopy (Axiovert 40).
Expression of P- and S-fimbriae was tested using mannose-resis-
tant (1% D-mannose; Roth) slide agglutination of 5% suspensions
of defibrinated human and bovine erythrocytes (Elocin Laboratory,
M€unchen, Germany), respectively (Blumer et al, 2005).
Experimental murine model of ascending UTI
Mice experiments were performed according to the guidelines for
the Care and Use of Laboratory Animals in compliance with Ger-
man regulations (Tierschutzgesetz). Permission for this study was
provided by the regional government (AZ 55.2-2531.01-53/09).
Mice (C57BL/6; female, 6–7 weeks old) were obtained from
Charles River Laboratories (Sulzfeld, Germany) and kept under spe-
cific pathogen-free conditions. For murine infection, the bacterial
strains were grown overnight under aerated conditions in LB
medium, harvested by centrifugation and resuspended in sterile
saline to a concentration of 1 × 1010 to 1 × 1011 CFU/ml. Groups of
8–15 C57BL/6 mice were transurethrally inoculated with 5 × 108–
5 × 109 CFU of strain 536 (UPEC, positive control), STEC O2:H6
strains 05-00787, 04-00955, or 03-08304, or non-pathogenic E. coli
K-12 strain MG1655 (negative control) as previously described
(Hagberg et al, 1983). In each case, animals were sacrificed 72 h
after infection. The bladder and kidneys were removed under ster-
ile conditions, rinsed extensively with 0.9% NaCl and homogenized
mechanically in 1 ml of 0.025% Triton-X 100, 0.9% NaCl. The
number of bacteria was quantified by scoring CFU after overnight
culture at 37°C on LB agar plates. The results were expressed as
CFU/g of tissue. Statistically significant differences in colonization
levels (P < 0.05) were assessed using Graphpad Prism 5 software.
If the bladder challenge data were normally distributed, they were
analyzed using an unpaired one-tailed t-test. Kidney infections were
analyzed using the unpaired, non-parametric one-tailed Mann-
Whitney test.
Supplementary information for this article is available online:
http://embomm.embopress.org
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